Breaking News Instant updates and real-time market news.

2019-04-18 10:29:32 PM Philip Morris $82.98 -2.515 (-2.94%) , BTI British American Tobacco $40.19 -0.17 (-0.42%) … 10:29 04/18/19 04/18 10:29 04/18/19 10:29	McConnell to introduce bill to raise minimum age to buy tobacco to 21, WBKO says Senate Majority Leader Mitch McConnell said he plans to introduce legislation in the U.S. Senate to raise the nationwide minimum age to buy tobacco products from 18 to 21, WBKO reports, citing a press conference. The McConnell bill, which will be introduced in May, will cover all tobacco products, including vaping devices. Publicly traded companies in the space include Altria Group (MO), British American Tobacco (BTI) and Philip Morris (PM). Reference Link PM Philip Morris $82.98 -2.515 (-2.94%) BTI British American Tobacco $40.19 -0.17 (-0.42%) MO Altria Group $54.84 -1.34 (-2.39%)	18 Apr 25 Apr 01 May 06 May 16 May
PM BTI MO PM Philip Morris $82.98 -2.515 (-2.94%) 02/27/19 02/27/19 UPGRADE Fly Intel: Top analyst upgrades Catch up on today's top analyst upgrades with this list compiled by The Fly: 1. Philip Morris (PM) upgraded to Buy from Neutral at UBS with analyst Robert Rampton saying the company's valuation hinges on its heated tobacco proposition, iQOS. 2. Boise Cascade (BCC) upgraded to Buy from Neutral at DA Davidson with analyst Steven Chercover saying that with the "irrational exuberance" having been shaken out of the stock, now is an "attractive entry point." 3. AptarGroup (ATR) upgraded to Outperform from Neutral at Baird. 4. W. R. Berkley (WRB) upgraded to Outperform from Neutral at Credit Suisse, while Cincinnati Financial (CINF) was upgraded to Neutral from Underperform. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. 03/06/19 JEFF 03/06/19 NO CHANGE JEFF Gottlieb resignation positive for tobacco sentiment, says Jefferies The resignation of FDA commissioner Scott Gottlieb is a net positive for tobacco sentiment, particularly for British American Tobacco (BTI) as it should lessen concerns related to any possible action around a menthol ban near term, Jefferies analyst Owen Bennett tells investors in a research note. A potential delay to guidelines around e-vapour restrictions could also support both British American and Imperial Brands (IMBBY), adds the analyst. 03/06/19 MSCO 03/06/19 NO CHANGE MSCO Resignation of Gottlieb lowers near-term overhang on Altria, says Morgan Stanley Morgan Stanley analyst Pamela Kaufman said she expects a positive reaction in tobacco stocks to the news that FDA Commissioner Scott Gottlieb will resign in April as it likely delays the agency's near-term tobacco control objectives. Gottlieb has been very vocal on tobacco regulation and his resignation creates a vacuum in leadership and uncertainty about the agency's strategy for tobacco control until a new head is appointed, though leadership at the Center of Tobacco Products remains intact under Mitch Zeller, Kaufman tells investors. While his resignation reduces the near-term regulatory overhang on Altria (MO), it could be a "mixed bag for e-cigs," as Gottlieb changed his tone last year due to the youth e-cig epidemic but he had previously increased leniency towards the category when he pushed out the PMTA deadline to 2022 from 2018, added Kaufman. 03/25/19 SBSH 03/25/19 NO CHANGE Target $102 SBSH Buy Philip Morris price target raised to $102 from $90 at Citi Citi analyst Adam Spielman raised his price target for Philip Morris to $102 from $90 citing the general increase in stock multiples. The analyst keeps a Buy rating on the shares. He did, however, reduce his earnings estimates for 2019 by 5% and for 2020 and beyond by 6% after Philip Morris' Canadian unit went into the local equivalent of Chapter 11. So far Canadian litigation has had little visible impact on tobacco shares, even for British American Tobacco (BTI), where the damages are much greater, Spielman tells investors in a research note. He thinks earnings reductions will affect Philip Morris in the short-term. However, in the medium-term the company's value will be determined by its success with reduced risk products, most notably iQos, says the analyst. BTI British American Tobacco $40.19 -0.17 (-0.42%) 01/29/19 01/29/19 UPGRADE Fly Intel: Top five analyst upgrades Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nvidia (NVDA) upgraded to Buy from Neutral at UBS with analyst Timothy Arcuri saying the 20% fiscal Q4 revenue miss preannounced and the stock drop "finally sets the stage for a new positive revision cycle starting this summer." 2. American Express (AXP) upgraded to Overweight from Neutral at Atlantic Equities. 3. BlackRock (BLK) upgraded to Buy from Hold at Jefferies with analyst Daniel Fannon saying it is benefiting from both structural shifts in investor behavior as well as secular trends and he believes the company can continue to deliver industry leading organic growth and capital return. 4. British American Tobacco (BTI) upgraded to Overweight from Neutral at Piper Jaffray with analyst Michael Lavery saying he views the stock's valuation as attractive at current levels and feels "modestly more comfortable" with Glo's patent litigation risk in Japan. 5. 3D Systems (DDD) and Stratasys (SSYS) were upgraded to Overweight from Neutral at Piper Jaffray. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. 03/28/19 SBSH 03/28/19 UPGRADE SBSH Buy British American Tobacco upgraded to Buy from Neutral at Citi Citi analyst Adam Spielman upgraded British American Tobacco (BTI) to Buy from Neutral and raised his price target for the shares to GBP 36 from GBP 30. The analyst believes organic revenue growth for tobacco companies will pick up this year as sales of next generation products accelerate. Further, the regulatory threat will probably move away from cigarettes, Spielman tells investors in a research note. He thinks an even greater focus on e-vapor cigarettes could be positive for both British American Tobacco and Imperial Brands (IMBYY). MO Altria Group $54.84 -1.34 (-2.39%) 02/25/19 JEFF 02/25/19 INITIATION JEFF Underperform Cronos Group initiated with an Underperform at Jefferies Jefferies analyst Owen Bennett initiated coverage of nine cannabis stocks, stating that his base-case "conservative" assumption is that the cannabis industry can grow in size to over $50B by 2029 from $17B in 2019. He started Cronos Group (CRON) with an Underperform rating and C$17 price target, stating that "at present we feel there is little to get really excited about other than the investment and large sum of money" from Altria (MO). He thinks "the market has gotten ahead of itself" on Cronos as he questions when Altria value creation will begin to materialize, Bennett tells investors. 03/05/19 COWN 03/05/19 INITIATION COWN Market Perform Cronos Group initiated with a Market Perform at Cowen Cowen analyst Vivien Azer started Cronos Group (CRON) with a Market Perform rating and C$29 price target. The analyst likes the company's story as an asset-light, global low-cost producer with operational support and invested capital from Altria Group (MO). However, Azer says the stock's current valuation prevents her from taking a more constructive position at this time.

2019-04-18 10:29:32

Philip Morris

$82.98: -2.515 (-2.94%)

, BTI

British American Tobacco

$40.19: -0.17 (-0.42%)

… 10:29

04/18/19

04/18

10:29

04/18/19

10:29

McConnell to introduce bill to raise minimum age to buy tobacco to 21, WBKO says

Senate Majority Leader Mitch McConnell said he plans to introduce legislation in the U.S. Senate to raise the nationwide minimum age to buy tobacco products from 18 to 21, WBKO reports, citing a press conference. The McConnell bill, which will be introduced in May, will cover all tobacco products, including vaping devices. Publicly traded companies in the space include Altria Group (MO), British American Tobacco (BTI) and Philip Morris (PM). Reference Link

Philip Morris

$82.98: -2.515 (-2.94%)

BTI

British American Tobacco

$40.19: -0.17 (-0.42%)

Altria Group

$54.84: -1.34 (-2.39%)

18
Apr
25
Apr
01
May
06
May
16
May

PM Philip Morris

$82.98: -2.515 (-2.94%)

02/27/19

03/06/19: JEFF

03/06/19: MSCO

03/25/19: SBSH

BTI British American Tobacco

$40.19: -0.17 (-0.42%)

01/29/19

03/28/19: SBSH

MO Altria Group

$54.84: -1.34 (-2.39%)

02/25/19: JEFF

03/05/19: COWN

TODAY'S FREE FLY STORIES

SRPT Sarepta $100.39 -1.15 (-1.13%) 18:31 12/12/19 12/12 18:31 12/12/19 18:31 Hot Stocks	Breaking Hot Stocks news story on Sarepta » Sarepta to resume trading… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ADBE Adobe $305.76 2.01 (0.66%) 18:25 12/12/19 12/12 18:25 12/12/19 18:25 Hot Stocks	Adobe CEO: We are not overly concerned with the trade war with China » Comment from interview… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec 23 Jan
SRPT Sarepta $100.39 -1.15 (-1.13%) 18:20 12/12/19 12/12 18:20 12/12/19 18:20 Hot Stocks	Sarepta announces FDA approval of VYONDYS 53 injection to treat DMD » Sarepta Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AMZN Amazon.com $1,760.44 11.33 (0.65%) 18:11 12/12/19 12/12 18:11 12/12/19 18:11 Hot Stocks	Amazon orders fourth season of 'The Marvelous Mrs. Maisel' » Amazon Studios announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
OHAI OHA Investment $1.28 (0.00%) , PTMN Portman Ridge Finance $2.04 (0.00%) 18:10 12/12/19 12/12 18:10 12/12/19 18:10 Hot Stocks	OHA Investment obtains stockholder approval of Portman Ridge deal » OHA Investment… OHAI OHA Investment $1.28 (0.00%) PTMN Portman Ridge Finance $2.04 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

ONCT Oncternal Therapeutics $4.62 0.05 (1.09%) 18:05 12/12/19 12/12 18:05 12/12/19 18:05 Hot Stocks	Oncternal presents interim data from Phase 1b clinical study of cirmtuzumab » Oncternal Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
HZN Horizon Global $3.49 0.14 (4.18%) 18:03 12/12/19 12/12 18:03 12/12/19 18:03 Hot Stocks	Horizon Global CFO Jamie Pierson steps down » Horizon Global announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ORCL Oracle $56.47 0.16 (0.28%) 18:03 12/12/19 12/12 18:03 12/12/19 18:03 Hot Stocks	Oracle CEO Catz says expects momentum in 2H20 to carry into FY21 » Says feels "very… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
SRPT Sarepta $100.39 -1.15 (-1.13%) 18:00 12/12/19 12/12 18:00 12/12/19 18:00 Hot Stocks	Breaking Hot Stocks news story on Sarepta » Sarepta trading halted,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ORCL Oracle $56.47 0.16 (0.28%) 17:52 12/12/19 12/12 17:52 12/12/19 17:52 Hot Stocks	Oracle's Ellison says 'we have no plans for having a second CEO' » Says there won't be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec

NLNK NewLink Genetics $1.61 -0.015 (-0.93%) , EVRC Evercel, Inc $0.00 (0.00%) 17:41 12/12/19 12/12 17:41 12/12/19 17:41 Hot Stocks	NewLink Genetics advances over 11% after Evercel discloses rejected offer » Shares of NewLink… NLNK NewLink Genetics $1.61 -0.015 (-0.93%) EVRC Evercel, Inc $0.00 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EVRC Evercel, Inc $0.00 (0.00%) , NLNK NewLink Genetics $1.61 -0.015 (-0.93%) 17:36 12/12/19 12/12 17:36 12/12/19 17:36 Hot Stocks	Evercel announces rejected offer to acquire NewLink Genetics » Evercel (EVRC) has made… EVRC Evercel, Inc $0.00 (0.00%) NLNK NewLink Genetics $1.61 -0.015 (-0.93%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
BXRX Baudax Bio $6.30 0.225 (3.70%) 17:34 12/12/19 12/12 17:34 12/12/19 17:34 Hot Stocks	Corsair Capital reports 8.77% passive stake in Baudax Bio » Corsair Capital disclosed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Dec
GVA Granite Construction $27.55 1.255 (4.77%) 17:33 12/12/19 12/12 17:33 12/12/19 17:33 Hot Stocks	Granite Construction subsidiary awarded $16M contract to rehabilitate I-94 » Granite Construction… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ENV Envestnet $71.58 -0.195 (-0.27%) 17:29 12/12/19 12/12 17:29 12/12/19 17:29 Syndicate	Breaking Syndicate news story on Envestnet » Envestnet files to sell… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

LULU Lululemon $224.48 -8.83 (-3.78%) 17:28 12/12/19 12/12 17:28 12/12/19 17:28 Syndicate	Lululemon holder Advent said to offer 2.6M shares, Bloomberg reports » Block offer range seen at… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ORCL Oracle $56.47 0.16 (0.28%) 17:26 12/12/19 12/12 17:26 12/12/19 17:26 Hot Stocks	Oracle sees FY20 CapEx approximately $2.2B » Sees FY20 tax rate… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
ORCL Oracle $56.47 0.16 (0.28%) 17:25 12/12/19 12/12 17:25 12/12/19 17:25 Earnings	Oracle sees 'double digit' EPS growth in FY20, consensus $3.88 » Sees FY20 revenue growing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
17:25 12/12/19 12/12 17:25 12/12/19 17:25 Conference/Events	Washington Association of Money Managers to hold a panel discussion » The Washington… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
ORCL Oracle $56.47 0.16 (0.28%) 17:24 12/12/19 12/12 17:24 12/12/19 17:24 Earnings	Oracle sees Q3 adjusted EPS 96c-98c, consensus 97c » Guidance in constant… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec

NPO EnPro $66.48 2.53 (3.96%) 17:22 12/12/19 12/12 17:22 12/12/19 17:22 Hot Stocks	EnPro company acquired by Arcline for $450M » Arcline Investment… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ORCL Oracle $56.47 0.16 (0.28%) 17:21 12/12/19 12/12 17:21 12/12/19 17:21 Hot Stocks	Oracle says Q2 'another solid quarter' » Says: Expects revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
NXPI NXP Semiconductors $123.98 2.54 (2.09%) 17:19 12/12/19 12/12 17:19 12/12/19 17:19 Hot Stocks	NXP Semiconductors director sells 13.5K shares of common stock » In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec 12 Dec
PFE Pfizer $38.54 0.3 (0.78%) 17:13 12/12/19 12/12 17:13 12/12/19 17:13 Hot Stocks	Pfizer says FDA approves XELJANZ XR tablets for treatment of UC » Pfizer announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ELS Equity Lifestyle $69.93 -1.13 (-1.59%) 17:12 12/12/19 12/12 17:12 12/12/19 17:12 Hot Stocks	Equity Lifestyle COO sells 18K shares of common stock » In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	28 Jan

Events

Earnings calls, analyst events, roadshows and more

Tomorrow at 00:00

Fish & Chips: Semiconductor & Networking Bus Tour Conferences

San Jose, CA
Tomorrow at 00:00

8th Annual ROTH Deer Valley Conference Conferences

Deer Valley, UT
BLRX
Tomorrow at 00:00

ESMO Immuno-Oncology Congress 2019 Conferences

Geneva
QLYS ...
Tomorrow at 00:00

17th Semi-Annual Silicon Valley Technology Bus Tour Conferences

Silicon Valley, CA
SONVY
Tomorrow at 00:00

8th Annual European Healthcare Field Trip Conferences

Basel/Zurich
Tomorrow at 00:00

Atlanta Bank Field Trip Conferences

Atlanta, GA
CRBP
Tomorrow at 00:00

Expert Symposium on Therapeutic Potential of Targeting Endocannabinoid System Conferences

Video Webcast
ATNX
Tomorrow at 00:00

San Antonio Breast Cancer Symposium 2019 Conferences

Henry B. Gonzalez Convention Center, San Antonio, TX
Tomorrow at 00:00

Greater China Corporate Day Conferences

Nomura NY Worldwide Plaza, New York, NY
Tomorrow at 00:00

European Multi-Industry Field Trip Conferences

Europe

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CRWD X CRWD Crowdstrike Block Trade Managers: Goldman Sachs Priced at: $49.40 2.2M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AUPH X AUPH Aurinia Pharmaceuticals Secondary Managers: Jefferies & SVB Leerink, H.C. Wainwright, Oppenheimer, Bloom Burton Priced at: $15.00 11.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XAIR X XAIR Beyond Air Secondary Managers: SunTrust, National Securities, Roth Capital, Laidlaw Priced at: $3.66 2.325M Shares ABR X ABR Arbor Realty Spot Secondary Managers: JPMorgan, JMP Securities & Raymond James Priced at: $14.14 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CFRX X CFRX ContraFect Spot Secondary Managers: Maxim Priced at: $.27 37.15M Shares RHP X RHP Ryman Hospitality Spot Secondary Managers: BofA/Merrill, JPMorgan & Wells Fargo Priced at: $85.60 3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SCYX X SCYX Scynexis Spot Secondary Managers: H.C. Wainwright Priced at: $.90 38.89M Shares
Tues	XP X XP XP IPO Managers: Goldman Sachs, JPMorgan, Morgan Stanley, XP & Itau BBA, BofA/Merrill, Citi, Credit Suisse, UBS Priced at: $27.00 72.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CNST X CNST Constellation Pharmaceuticals Spot Secondary Managers: JPMorgan, Jefferies & Cowen, RBC Capital, SunTrust Priced at: $34.50 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GMRE X GMRE Global Medical REIT Spot Secondary Managers: Stifel, BMO Capital, Baird, KeyBanc & SunTrust Priced at: $13.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Jaffray & Stifel, BTIG, JMP Securities, SunTrust Priced at: $36.50 1.57M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDGL X MDGL Madrigal Pharmaceuticals Spot Secondary Managers: Goldman Sachs Priced at: $107.85 1.2M Shares MRNS X MRNS Marinus Pharmaceuticals Spot Secondary Managers: Oppenheimer & Ladenburg Priced at: $1.25 28M Shares PACK X PACK Ranpak Holdings Spot Secondary Managers: Craig-Hallum Priced at: $6.50 15.384M Shares PMT X PMT PennyMac Mortgage Spot Secondary Managers: Morgan Stanley, Credit Suisse, BofA/Merrill, JPMorgan & Barclays, Nomura Instinet, Piper Jaffray Priced at: $22.10 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCKT X RCKT Rocket Pharmaceuticals Spot Secondary Managers: JPMorgan, Cowen & Evercore ISI, LifeSci Priced at: $22.25 3.82M Shares
Wed	BILL X BILL Bill.com IPO Managers: Goldman Sachs, BofA/Merrill, Jefferies & KeyBanc, Canaccord, Needham, William Blair Priced at: $22.00 9.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EH X EH Ehang IPO Managers: Morgan Stanley, Needham, Tigress Financial, Prime Number Priced at: $12.50 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LVGO X LVGO Livongo Health Secondary Managers: Morgan Stanley, Goldman Sachs & JPMorgan Priced at: $27.00 2.78M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MNRL X MNRL Brigham Minerals Secondary Managers: Credit Suisse, Goldman Sachs & RBC Capital Priced at: $18.10 11M Shares MNTA X MNTA Momenta Secondary Managers: Goldman Sachs & JPMorgan, Stifel Priced at: $15.50 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AKTS X AKTS Akoustis Spot Secondary Managers: Craig-Hallum, Roth Capital, Loop Capital Priced at: $6.25 4.8M Shares ASMB X ASMB Assembly Biosciences Spot Secondary Managers: Jefferies & SVB Leerink Priced at: $16.50 5.152M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FTSV X FTSV Forty Seven Spot Secondary Managers: Morgan Stanley & Credit Suisse Priced at: $35.00 4.86M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HCCO X HCCO Healthcare Merger Corp. IPO Managers: Cantor Fitzgerald Priced at: $10.00 22M Shares
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	OCFT X OCFT OneConnect IPO Managers: Morgan Stanley, Goldman Sachs, JPMorgan & Ping An of China, BofA/Merrill, HSBC, CLSA, KeyBanc $9.00-10.00 26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SPT X SPT Sprout Social IPO Managers: Goldman Sachs, Morgan Stanley, KeyBanc & William Blair, Canaccord, Stifel $16.00-18.00 8.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AQST X AQST Aquestive Therapeutics Secondary Managers: BMO Capital $7.51 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PHR X PHR Phreesia Secondary Managers: JPMorgan, Wells Fargo, William Blair, Allen & Co., Piper Jaffray, Baird, Raymond James $28.72 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

McConnell to introduce bill to raise minimum age to buy tobacco to 21, WBKO says

TODAY'S FREE FLY STORIES

Get Full Fly Access